population pharmacokinetics
Recently Published Documents


TOTAL DOCUMENTS

2143
(FIVE YEARS 466)

H-INDEX

66
(FIVE YEARS 8)

2022 ◽  
Vol Volume 15 ◽  
pp. 53-62
Author(s):  
Matthias Gijsen ◽  
Omar Elkayal ◽  
Pieter Annaert ◽  
Ruth Van Daele ◽  
Philippe Meersseman ◽  
...  

Author(s):  
Soedarsono Soedarsono ◽  
Rannissa Puspita Jayanti ◽  
Ni Made Mertaniasih ◽  
Tutik Kusmiati ◽  
Ariani Permatasari ◽  
...  

2022 ◽  
pp. 137-150
Author(s):  
Ophelia Yin ◽  
Raymond Miller

Author(s):  
Naoki Kotani ◽  
Michael Dolton ◽  
Robin J. Svensson ◽  
Jakob Ribbing ◽  
Lena E. Friberg ◽  
...  

2021 ◽  
Vol 9 (3) ◽  
Author(s):  
Jongsung Hahn ◽  
Kyoung Lok Min ◽  
Soyoung Kang ◽  
Seungwon Yang ◽  
Min Soo Park ◽  
...  

To the best of our knowledge, this is the first large prospective pharmacokinetic/pharmacodynamic (PK/PD) study of piperacillin-tazobactam in ECMO patients. We used piperacillin-tazobactam plasma concentration data from four different cases (concomitant use of ECMO and CVVHDF, receiving ECMO only, weaned from ECMO and receiving CVVHDF, and weaned from ECMO and not receiving CVVHDF) to provide preliminary insights into the incremental effects of critical illness, ECMO, and CVVHDF on PK.


Sign in / Sign up

Export Citation Format

Share Document